Guarding Health,
Shielding Futures
Continuous Defense Technologies to
Combat Healthcare Infections and Antimicrobial Resistance
Leading the Charge Against Antimicrobial Resistance
Technology Pipeline
Program
Microbicidal Coating Technology
Keep Klear™
Continuously active transparent microbicidal coating technology: offering a 7-day residual effect
-
Discovery
-
Preclinical
-
Phase1
-
Phase2
-
Discovery
-
Preclinical
-
Phase1
-
Phase2
Partners
Antimicrobial Fabric Technology
Micro Dome®
Antimicrobial fabrics: Safeguarding healthcare settings by inhibiting the growth of drug-resistant pathogens
-
Discovery
-
Preclinical
-
Phase1
-
Phase2
Confidential
Adjuvant Antibiotic Platform
PRP-2019
Optimizing inactive commercial antibiotics for infectious diseases: Boosting effectiveness with adjuvant antibiotic technology
-
Discovery
-
Preclinical
-
Phase1
-
Phase2
Challenges Overview
AMR
HAI
Science Spotlight: Insights & Innovations
Threat of antimicrobial resistance in INDIA and its implications
In the early 2000’s an intestinal superbug began quietly spreading through hospitals around the world causing a deadly form of diarrhea among immune compromised patients.
Sugar Shock: Unveiling the Alarming Link Between Trehalose and C. difficile Infections
In the early 2000’s an intestinal superbug began quietly spreading through hospitals around the world causing a deadly form of diarrhea among immune compromised patients.
Battling Superbugs Beyond Earth: The Fight Against Multi-Drug Resistant Bacteria on the International Space Station
Looking up at the night sky brings to mind flights of fancy and travelling through space on far off adventures. In reality, astronauts on the International Space Station (ISS) are still learning the challenges of long-term space travel and living in space.